Category:Daniel La of Chestnut Hill MA (US)
Daniel La of Chestnut Hill MA (US)
Executive Summary
Daniel La of Chestnut Hill MA (US) is an inventor who has filed 2 patents. Their primary areas of innovation include STEROIDS (seco-steroids (1 patents), STEROIDS (seco-steroids (1 patents), Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms (1 patents), and they have worked with companies such as Sage Therapeutics, Inc. (2 patents). Their most frequent collaborators include (2 collaborations), (2 collaborations), (2 collaborations).
Patent Filing Activity
File:Daniel La of Chestnut Hill MA (US) Monthly Patent Applications.png
Technology Areas
File:Daniel La of Chestnut Hill MA (US) Top Technology Areas.png
List of Technology Areas
- C07J31/006 (STEROIDS (seco-steroids): 1 patents
- C07J9/005 (STEROIDS (seco-steroids): 1 patents
- C07J73/003 (Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms): 1 patents
Companies
File:Daniel La of Chestnut Hill MA (US) Top Companies.png
List of Companies
- Sage Therapeutics, Inc.: 2 patents
Collaborators
- Francesco G. Salituro of Marlborough MA (US) (2 collaborations)
- Albert Jean Robichaud of Boston MA (US) (2 collaborations)
- Boyd L. Harrison of Princeton Junction NJ (US) (2 collaborations)
- Gabriel Martinez Botella of Wayland MA (US) (1 collaborations)
- Andrew Griffin (1 collaborations)
- Maria Jesus Blanco-Pillado of Arlington MA (US) (1 collaborations)
Subcategories
This category has the following 7 subcategories, out of 7 total.
A
B
D
F
G
- Francesco G. Salituro of Marlborough MA (US)
- Albert Jean Robichaud of Boston MA (US)
- Boyd L. Harrison of Princeton Junction NJ (US)
- Pages with broken file links
- Gabriel Martinez Botella of Wayland MA (US)
- Andrew Griffin
- Maria Jesus Blanco-Pillado of Arlington MA (US)
- Daniel La of Chestnut Hill MA (US)
- Inventors
- Inventors filing patents with Sage Therapeutics, Inc.